29 November 2019

Gijs Overheul, Pascal Miesen and Ronald van Rij, dept. of Medical Microbiology, theme Infectious diseases and global health, have elucidated the mechanism by which a DNA virus evades small RNA-based immunity of the host. They have published their results in PNAS.

Host immunity exerts strong selection pressure on viruses, often leading to the evolution of viral mechanisms to evade or suppress the immune response. It is well established that RNA interference (RNAi) is a potent antiviral immune system against RNA viruses. As a counter-defense, RNA viruses often encode proteins that suppress the RNAi response. RNAi also targets DNA viruses, but the antiviral effects seem to be modest.

Using the fruit fly Drosophila melanogaster and a large DNA virus of insects (IIV6) as model system, the research group of Van Rij, including former PhD candidates Walter Bronkhorst and Rob Vogels, has studied the complex interactions between virus and host RNAi. The researchers now show that wildtype IIV6 is indeed mostly insensitive to RNAi, but that an IIV6 mutant lacking its RNAi antagonistic protein becomes extremely sensitive to RNAi. Thus, RNAi is in fact strongly antiviral against DNA viruses, but virus-encoded immune antagonists can fully mask this antiviral activity.

On the photo, from left to right: Ronald van Rij, Gijs Overheul, Pascal Miesen
 

Related news items


David Burger top scientist on anti-HIV medication

6 December 2021

Professor of Clinical Pharmacy David Burger, affiliated with the Radboudumc Pharmacy, is in the list of top scientists in the field of anti-HIV medication.

read more

How much should we exercise to live healthier lives? Research into the relationship between exercise, heart disease and mortality

3 December 2021

It has long been known that exercise reduces the risk of many chronic diseases. However, we do not yet know exactly how much exercise is necessary to achieve health benefit.

read more

KNAW Early Career Award for Martine Hoogman

2 December 2021

Martine Hoogman has been awarded a KNAW Early Career Award. The prize, a sum of 15,000 euros and a work of art, is aimed at researchers in the Netherlands who are at the start of their careers and have innovative, original research ideas.

read more

T-Guard can reset immune system

1 December 2021

For 20 years, the Nijmegen based Radboudumc spin-off company Xenikos has been working on a drug that can reset the immune system. This reset will save lives of seriously ill patients. Now, after years of hard work, the moment of truth has arrived for T-guard.

read more

Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI

1 December 2021

Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.

read more

Villa Joep Research Grant for Radiotherapy & OncoImmunology (ROI) lab

1 December 2021

Renske van den Bijgaart and Gosse Adema from the Radiotherapy & OncoImmunology laboratorium in collaboration with the Prinses Maxima Center received a grant from Villa Joep of 410k Euro.

read more